Cubist Systematic Strategies’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,740
| Closed | -$565K | – | 3974 |
|
|
2022
Q3 | $565K | Sell |
3,740
-1,414
| -27% | -$214K | ﹤0.01% | 2426 |
|
|
2022
Q2 | $751K | Sell |
5,154
-8,432
| -62% | -$1.23M | ﹤0.01% | 2312 |
|
|
2022
Q1 | $1.61M | Buy |
13,586
+8,941
| +192% | +$1.06M | 0.01% | 1671 |
|
|
2021
Q4 | $640K | Buy |
+4,645
| New | +$640K | 0.01% | 2267 |
|
|
2021
Q3 | – | Sell |
-9,727
| Closed | -$944K | – | 3353 |
|
|
2021
Q2 | $944K | Buy |
9,727
+6,613
| +212% | +$642K | 0.01% | 1613 |
|
|
2021
Q1 | $213K | Sell |
3,114
-46,483
| -94% | -$3.18M | ﹤0.01% | 2432 |
|
|
2020
Q4 | $4.25M | Buy |
49,597
+38,284
| +338% | +$3.28M | 0.06% | 520 |
|
|
2020
Q3 | $735K | Buy |
11,313
+7,940
| +235% | +$516K | 0.01% | 1510 |
|
|
2020
Q2 | $247K | Buy |
+3,373
| New | +$247K | ﹤0.01% | 1942 |
|
|
2020
Q1 | – | Sell |
-22,800
| Closed | -$1.24M | – | 2674 |
|
|
2019
Q4 | $1.24M | Buy |
+22,800
| New | +$1.24M | 0.02% | 1025 |
|
|
2019
Q3 | – | Sell |
-6,884
| Closed | -$301K | – | 2693 |
|
|
2019
Q2 | $301K | Buy |
6,884
+5,657
| +461% | +$247K | 0.01% | 1800 |
|
|
2019
Q1 | $63K | Sell |
1,227
-22,862
| -95% | -$1.17M | ﹤0.01% | 2068 |
|
|
2018
Q4 | $891K | Buy |
24,089
+4,750
| +25% | +$176K | 0.04% | 621 |
|
|
2018
Q3 | $726K | Buy |
19,339
+10,376
| +116% | +$390K | 0.04% | 606 |
|
|
2018
Q2 | $354K | Buy |
+8,963
| New | +$354K | 0.02% | 978 |
|
|
2018
Q1 | – | Sell |
-12,492
| Closed | -$337K | – | 2260 |
|
|
2017
Q4 | $337K | Buy |
+12,492
| New | +$337K | 0.02% | 1171 |
|
|
2017
Q3 | – | Sell |
-8,592
| Closed | -$215K | – | 2172 |
|
|
2017
Q2 | $215K | Buy |
+8,592
| New | +$215K | 0.01% | 1248 |
|